<VariationArchive RecordType="classified" VariationID="817028" VariationName="NM_030632.3(ASXL3):c.4153_4154del (p.Val1385fs)" VariationType="Deletion" Accession="VCV000817028" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-05-07" DateCreated="2020-03-16" MostRecentSubmission="2023-04-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="806012" VariationID="817028">
      <GeneList>
        <Gene Symbol="ASXL3" FullName="ASXL transcriptional regulator 3" GeneID="80816" HGNC_ID="HGNC:29357" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="33578219" stop="33751195" display_start="33578219" display_stop="33751195" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="31158540" stop="31327398" display_start="31158540" display_stop="31327398" Strand="+" />
          </Location>
          <OMIM>615115</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_030632.3(ASXL3):c.4153_4154del (p.Val1385fs)</Name>
      <CanonicalSPDI>NC_000018.10:33743999:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="33744000" stop="33744001" display_start="33744000" display_stop="33744001" variantLength="2" positionVCF="33743999" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="31323964" stop="31323965" display_start="31323964" display_stop="31323965" variantLength="2" positionVCF="31323963" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V1385fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.33744001_33744002del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.33744001_33744002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.31323965_31323966del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.31323965_31323966del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_055244.1" sequenceAccession="NG_055244" sequenceVersion="1" change="g.170425_170426del">
            <Expression>NG_055244.1:g.170425_170426del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030632.3" sequenceAccession="NM_030632" sequenceVersion="3" change="c.4153_4154del" MANESelect="true">
            <Expression>NM_030632.3:c.4153_4154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_085135.1" sequenceAccession="NP_085135" sequenceVersion="1" change="p.Val1385fs">
            <Expression>NP_085135.1:p.Val1385fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1599572974" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_030632.3(ASXL3):c.4153_4154del (p.Val1385fs) AND not provided" Accession="RCV001008081" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030632.3(ASXL3):c.4153_4154del (p.Val1385fs) AND Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" Accession="RCV003223416" Version="2">
        <ClassifiedConditionList TraitSetID="12061">
          <ClassifiedCondition DB="MedGen" ID="C4750837">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-03-16" MostRecentSubmission="2023-04-30">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="Suggested Reading" Abbrev="Zhu et al., 2015">
          <ID Source="PubMed">25590979</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12061" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18330" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</ElementValue>
                <XRef ID="MONDO:0014205" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bainbridge-Ropers syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRPS</ElementValue>
                <XRef Type="MIM" ID="615485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ASXL3-related disorder is characterized by developmental delay or intellectual disability, typically in the moderate to severe range, with speech and language delay and/or absent speech. Affected individuals may also display autistic features. There may be issues with feeding. While dysmorphic facial features have been described, they are typically nonspecific. Affected individuals may also have hypotonia that can transition to spasticity resulting in unusual posture with flexion contractions of the elbows, wrists, and fingers. Other findings may include poor postnatal growth, strabismus, seizures, sleep disturbance, and dental anomalies.</Attribute>
                <XRef ID="NBK563693" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ASXL3-Related Disorder</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33151654</ID>
                <ID Source="BookShelf">NBK563693</ID>
              </Citation>
              <XRef ID="352577" DB="Orphanet" />
              <XRef ID="C4750837" DB="MedGen" />
              <XRef ID="MONDO:0014205" DB="MONDO" />
              <XRef Type="MIM" ID="615485" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2305813" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:183798|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167820" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.4153_4154delGT variant in the ASXL3 gene has been reported previously in the literature (described as c.4152_4153delTG using alternate nomenclature) in an individual with Bainbridge-Ropers syndrome (Zhu et al., 2015). The c.4153_4154delGT variant causes a frameshift starting with codon Valine 385, changes this amino acid to an Isoleucine residue, and creates a premature Stop codon at position 14 of the new reading frame, denoted p.Val1385IlefsX14. This variant is predicted to cause loss of normal protein function through protein truncation as the last 864 amino acids are replaced with 13 incorrect residues. The c.4153_4154delGT variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.4153_4154delGT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030632.1:c.4153_4154delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7326548" SubmissionDate="2023-04-20" DateLastUpdated="2023-04-30" DateCreated="2023-04-30">
        <ClinVarSubmissionID localKey="NM_030632.1:c.4153_4154delGT|OMIM:615485" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003918908" DateUpdated="2023-04-30" DateCreated="2023-04-30" Type="SCV" Version="1" SubmitterName="Duke University Health System Sequencing Clinic, Duke University Health System" OrgID="505392" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25590979</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030632.1:c.4153_4154delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615485" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13113956</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7326548" TraitType="Disease" MappingType="XRef" MappingValue="615485" MappingRef="OMIM">
        <MedGen CUI="C4750837" Name="Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305813" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

